The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues (Q34116326)

31 July 2017

1 reference

title

The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues (English)

1 reference

31 July 2017

0 references

1 reference

3

Susan L McElroy

1 reference

31 July 2017

Marlene P Freeman

1

1 reference

PubMed ID

11869778

31 July 2017

Scott A Freeman

series ordinal

2

1 reference

31 July 2017

1 February 2002

1 reference

Journal of Affective Disorders

31 July 2017

1 reference

31 July 2017

68

1 reference

31 July 2017

1-23

1 reference

31 July 2017

1

1 reference

Gabapentin in the acute treatment of refractory bipolar disorder.

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The emerging epidemiology of hypomania and bipolar II disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Clonazepam treatment of five lithium-refractory patients with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Guidelines for the rational use of benzodiazepines. When and what to use.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Inositol monophosphatase, the putative therapeutic target for lithium

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Plasma 3-methoxy-4-hydroxyphenylglycol in manic patients: relationships with clinical variables

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Behavioral treatment in two cases of obsessive-compulsive disorder with concomitant bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Antidepressant-associated hypomania in outpatient depression: a 203-case study in private practice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Valproate as an alternative in post-traumatic stress disorder: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Olanzapine compared to lithium in mania: a double-blind randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

CSF GABA in euthymic manie-depressive patients and controls

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Cerebrospinal fluid and plasma monoamines and their metabolites in euthymic bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Mood swings in patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Role of gamma-aminobutyric acid in antipanic drug efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Investigation of dopamine system genes in obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Spectrum of efficacy of valproate in 55 patients with rapid-cycling bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Clozapine for treatment-refractory mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A factor analysis of the signs and symptoms of mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Signs and symptoms of mania in pure and mixed episodes.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Comorbidity of panic disorder in bipolar illness: evidence from the Epidemiologic Catchment Area Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Comorbidity for obsessive-compulsive disorder in bipolar and unipolar disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A case of mania induced by high-dose fluoxetine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Dopamine D2 receptor (DRD2) gene and susceptibility to posttraumatic stress disorder: a study and replication.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Valproate monotherapy in an SRI-intolerant OCD patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The role of serotonin in panic, anxiety and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Review of current treatment in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of social phobia with clonazepam and placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Rapid switch in a bipolar patient during lithium-tricyclic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Suicidality, panic disorder and psychosis in bipolar depression, depressive-mania and pure-mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Quetiapine for treatment-resistant mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Li+ stimulates ATP-regulated dopamine uptake in PC12 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Comparison of Alprazolam, Imipramine, and Placebo in the Treatment of Depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Anxiety as a correlate of response to the acute treatment of bipolar I disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lithium for irritability in post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Valproate/nortriptyline interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Inositol treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Fluoxetine and parkinsonism in patients taking carbamazepine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Plasma levels of gamma-aminobutyric acid and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

GABA levels in CSF of patients with psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Combined lithium-tricyclic treatment of obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

1 reference

7 January 2021

Somatic treatment of catatonia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Social anxiety, hypomania and the bipolar spectrum: data, theory and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lithium prophylaxis of tricyclic-antidepressant-induced mania in bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Fluvoxamine-associated mania/hypomania in patients with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of generalized anxiety disorder with venlafaxine: a series of 11 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Urinary catecholamines and plasma hormones predict mood state in rapid cycling bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Behavioral indications for serotonin receptor hypersensitivity in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: a prospective, placebo-controlled comparison.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lamotrigine toxicity secondary to sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Valproate treatment of panic disorder and lactate-induced panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Outcome and comorbidity in first- compared with multiple-episode mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The epidemiology of DSM-III-R bipolar I disorder in a general population survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Carbamazepine but not valproate induces bupropion metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Rapid efficacy of olanzapine augmentation in nonpsychotic bipolar mixed states

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Low dose lithium carbonate in the treatment of post traumatic stress disorder: brief communication.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Sustained urinary norepinephrine and epinephrine elevation in post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Comorbidity of obsessive compulsive disorder in bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Withdrawal hypomania associated with paroxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Double-blind, controlled trial of inositol treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Inositol-induced mania?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Panic disorder with familial bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Bupropion and secondary mania. Is there a relationship?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Possible induction of mania by buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Olanzapine in treatment-resistant bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Pharmacologic agents for the treatment of acute bipolar mania.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of Panic Disorder and Benzodiazepine Withdrawal With Valproate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Differences and similarities in mixed and pure mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Buspirone-induced mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Long-term use of benzodiazepines: tolerance, dependence and clinical problems in anxiety and mood disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The effects of valproate in brain monoamines of juvenile rats after stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Effects of carbamazepine on plasma haloperidol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Paroxetine-induced mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of social phobia with gabapentin: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Development of obsessive-compulsive symptoms during clozapine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Development of transient obsessive-compulsive symptoms during treatment with clozapine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Alprazolam-induced manic episode in two patients with panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Altered platelet alpha 2-adrenergic binding sites in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Depressive comorbidity of panic, social phobic, and obsessive–compulsive disorders re-examined: is there a bipolar ii connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Anxious-bipolar comorbidity. Diagnostic and treatment challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Plasma GABA predicts acute response to divalproex in mania

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Dopaminergic function in panic disorder: Comparison with major and minor depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Gabapentin as a potential treatment for anxiety disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Valproate in the treatment of acute mania. A placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Dysphoric mania. Clinical and biological correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Valproic acid and panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Plasma GABA in children and adolescents with mood, behavior, and comorbid mood and behavior disorders: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Prophylactic lithium carbonate with and without imipramine for bipolar 1 patients. A double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Risperidone and obsessive-compulsive symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The pharmacologic basis of antiepileptic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Thiothixene and Thioridazine in Anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Cerebrospinal fluid gamma-aminobutyric acid in patients with panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

CSF GABA in depressed patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Alprazolam in bipolar-I depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment-resistant bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Adjunctive clonazepam for maintenance treatment of bipolar affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A case of severe lithium toxicity induced by combined fluoxetine and lithium carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Affective comorbidity in panic disorder: is there a bipolar connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Gabapentin in the treatment of bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Mania in a panic disorder patient treated with fluoxetine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Cerebrospinal fluid MHPG. An assessment of norepinephrine metabolism in affective disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Hypomania associated with mirtazapine augmentation of sertraline

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A potential drug interaction between fluoxetine and valproic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of acute bipolar depression: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of acute mania with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Fluoxetine-induced mania in a patient with obsessive-compulsive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of obsessive-compulsive disorder with lithium carbonate

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Posttraumatic stress disorder and partial complex seizures.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Three case reports of acute paroxysmal excitement associated with alprazolam treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The co-occurrence of mania with medical and other psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Use of clomipramine in treatment of obsessive-compulsive symptomatology

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Depression during mania. Treatment response to lithium or divalproex.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Carbamazepine in obsessive-compulsive disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The prevalence of major depressive and bipolar disorders in Hungary. Results from a national epidemiologic survey.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Divalproex in posttraumatic stress disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

d-fenfluramine-induced prolactin responses in mania: evidence for serotonergic subsensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A double-blind, controlled comparison of the novel antipsychotic olanzapine versus haloperidol or placebo on anxious and depressive symptoms accompanying schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Carbamazepine in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Lack of efficacy of carbamazepine in the treatment of panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

A review of 19 double-blind placebo-controlled studies in social anxiety disorder (social phobia).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Treatment of Refractory Rapid Cycling Bipolar Disorder With Risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

The effect of citalopram in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Adjunctive Use of Olanzapine in Mood Disorders: Five Case Reports

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Anxious and non-anxious bipolar disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Reduced brain 5-HT and elevated NE turnover and metabolites in bipolar affective disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Acute treatment of bipolar depression with gabapentin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Probable nefazodone-induced mania in a patient with unreported bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

Trauma and posttraumatic stress disorder in severe mental illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-0327%2800%2900299-8

7 January 2021

10.1016/S0165-0327(00)00299-8

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11869778